Several lines of CHO cells stably overexpressing protein kinase C (PKC) subspecies to various extents were established by the DNA-mediated transfer. Upon treatment with phorbol 12-myristate 13-acetate, the growth of the cells expressing the PKC-6 subspecies was markedl inhibited, whereas cell lines expressing PKC-a, PKC-IH, and PKC-C subspecies were not sign tly affected. Flow cytometric analysis indicated that all cell les overexpressing PKC-8 subspecies accumulated in G2/M phase in response to phorbol 12-myristate 13-acetate. In these arrete cells, dikaryons were predominant, implying that phorbol ester-induced inhibition of cell division is specific to telophase. These results suggest PKC-6 subspecies may play a role in the normal cell cycle progression.
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Protein kinase C (PKC) appears to play crucial roles in signal transduction leading to cell growth and differentiation. This enzyme was first shown to be activated by diacylglycerol generated by the receptor-mediated hydrolysis of inositol phospholipids and has been identified as a major receptor of tumor-promoting phorbol esters (1). Molecular cloning and biochemical studies have revealed that the PKC family is a large family, consisting ofat least eight subspecies, a, 3PI, /11, y, 8, E, A, and q (PKC-L) in mammalian'tissues (2-5). These subspecies show subtly different enzymological properties and distinct tissue distribution. Molecular genetic approaches have also been used to explore the role of this PKC family in cell proliferation by expressing defined enzyme subspecies, such as PKC-a, PKC-P, or PKC-y, in mammalian cells (6) (7) (8) (9) (10) (11) . In some cell lines stably overproducing PKC subspecies, growth promotion such as enhanced growth rates, increased saturation densities, and anchorageindependent growth has been observed (6, 7, 9, 10) . On the other hand, when the PI subspecies was overexpressed, growth inhibition and tumor suppression in HT29 colon cancer cells were observed (11) . In contrast, when a mutant a subspecies, designated UV25, was expressed in NIH 3T3 cells, it appeared to cause malignant transformation (12 
MATERIALS AND METHODS
Construction of Expression Plasmids. cDNAs for rat PKC-a, -/311, -8, and -C subspecies were excised from plasmids pTB755, pTB708, pTB808, and pTB949, respectively (14) (15) (16) (17) , by complete or partial digestion with EcoP. These cDNAs were then separately inserted downstream of the Abelson murine leukemia virus long terminal repeat in plasmid pTB399 (18) by replacing the interleukin 2 sequence. The long terminal repeat-PKC cDNA segments between Sal I and Cla I sites ofthese plasmids were transferred to the same sites of plasmid pTB348 (18) , which carried the hamster dihydrofolate reductase (DHFR) cDNA under the control of the simian virus 40 early promoter. The resulting expression plasmids for the a, .3II, 8, and ; subspecies are referred to as pTB789, pTB705, pTB1322, and pTB1324, respectively. All the procedures were done as described (19) .
Transfection, Selection, and Gene Amplification. DHFR-CHO cells (20) were transfected with each of the expression constructs by the calcium phosphate-DNA coprecipitation method (21) . DHFR+ transformants were selected by colony formation in Dulbecco's modified Eagle's medium (DMEM) containing 10%6 (vol/vol) dialyzed fetal bovine serum and proline (35 ,Ag/ml). Gene amplification was conducted by a stepwise increase of methotrexate in the culture medium as described (22) . The clones isolated were cultured in DMEM containing 5% fetal bovine serum and proline (35 , The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. ml) and boiled for 5 min, and 40 1. of each extract was subjected to SDS/PAGE (23) on 8% gels and transferred to a nitrocellulose sheet (24) . Rabbit polyclonal antibodies CKpV38-a (25) and CKpV5C-a (17) , which specifically recognize the 8 and ; subspecies, respectively, were employed as first antibodies. Immunoblot analysis was carried out using anti-rabbit second antibody conjugated to alkaline phosphatase by the immunoblotting system supplied by Promega as described (26) .
Cell Growth Analysis. Cells were seeded on 24-well plates at 3 x 104 cells in DMEM containing 5% fetal bovine serum and proline (35 Ag/ml) at 0.5 ml per well. The next day (day 0), PMA at the final concentration of 50 nM was added, and the medium was changed every 2 days. The concentrations of PMA and dimethyl sulfoxide ( ing the a, 83II, and C subspecies (Fig. 2) . PMA also inhibited the growth of CHO 8-25 and CHO 8-33 cells, which overexpress the 8 subspecies but at a level lower than that of CHO 8-27 and CHO 8-47 cells. Treatment of CHO 8-27 and CHO 8-47 cells with PMA resulted in a morphological change-cells became small and rounded-up, whereas PMA had no effect on the fibroblast morphology of control CHOd+ cells, CHO a-106, CHO 1II-101, and CHO C-13 cells (Fig. 3) . The morphological characteristics of the PMA-treated CHO 8-27 and CHO 8-47 cells were similar to those of a cell in M phase of the cell cycle. These cells were easily detached from the culture plates by gentle pipetting, as is frequently observed with mitotic cells.
Cell Cycle Analysis of Growth Inhibition. The cell cycle analysis by flow cytometry indicated that 31%, 50%, and 19%o of the subconfluent CHO 8-27 cells growing in the absence of PMA were in G1, S, and G2/M phases, respectively. In the presence of PMA, however, >40%o of the cells treated with PMA for 24 hr were in G2/M phase (Fig. 4 C and D) . in G2/M phase was 40%o in both cases (Fig. 4 A and B) . Observation at higher magnification revealed that many PMA-treated CHO 8-27 cells were dikaryons (Fig. 5) . The results indicated that the PMA-treated cell lines overexpressing the 8 subspecies are arrested at G2/M phase and that the inhibition ofcell growth is due to the inhibition of cytokinesis, rather than mitosis.
DISCUSSION
The eukaryotic cell cycle from G2 to M phase is regulated by a network of protein kinases and phosphatases (27, 28) . One of the key proteins involved in this regulatory network is protein kinase cdc2, which is a component of the M-phasepromoting factor, having a cell-cycle-regulated histone H1 kinase activity. The regulation of this M-phase-promoting factor is critical for the G2-M transition. In the present studies, we show that cells overexpressing the 8 subspecies are arrested at G2/M phase of cell cycle by treatment with PMA. The cell lines expressing one of several other PKC subspecies did not show such an abnormality. The a and 8 subspecies are the major PKC subspecies normally expressed in the CHO cells, whereas other PKC subspecies were not detected. CHO cells overexpressing the 8 subspecies seem to undergo normal mitotic division, except for the final step of cytokinesis, since many of the arrested cells are telophase-like dikaryons. As assayed by Northern blot analysis (16, 29) , the 8 subspecies is expressed in all tissues so far examined including brain, lung, spleen, kidney, skin, and intestine. Among cultured cells, neuroblastoma cells, EL4 thymoma cells, and many other hematopoietic cell lines, the 8 subspecies transcript is a major PKC subspecies transcript (30) (31) (32) . Immunoblot analysis has indicated (29, 31, 33, 34) that the 8 (36, 37) . Genetic analysis of PKCI will provide information on the role of the PKC family in cell cycle regulation. Recently, it has been reported (38) (1992) 
